Anavo Therapeutics
Anavo Therapeutics utilizes its IGNITE platform to develop allosteric modulators that target phosphatases, a class of enzymes previously considered undruggable. The company focuses on creating a proprietary portfolio of therapeutic programs for cancer and autoimmune diseases by addressing signaling pathway imbalances. It also provides platform support to partners for drug discovery across various therapeutic indications.
Visit websiteLeiden, Netherlands
Biotechnology
Pharmaceuticals
Oncology
Autoimmune Disease
Funding summary
- Total raised
- €8.5M
- Funding rounds
- 1
Investors in Anavo Therapeutics
Investors on record for Anavo Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Anavo Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors